Therefore, in the future, large-scale clinical studies can be conducted to collect NR3C1 and FAAH gene information and epilepsy drug treatment response data, and analyze the relationship between NR3C1 and FAAH gene polymorphisms and epilepsy drug response. This evidence concerns the gene FAAH and epilepsy.